BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,065 filers reported holding BAXTER INTL INC in Q2 2019. The put-call ratio across all filers is 1.42 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $332,000 | -13.5% | 4,279 | -4.4% | 0.02% | -14.3% |
Q4 2021 | $384,000 | -6.3% | 4,478 | -12.2% | 0.03% | -15.2% |
Q3 2021 | $410,000 | -8.5% | 5,103 | -8.2% | 0.03% | -10.8% |
Q2 2021 | $448,000 | -6.1% | 5,561 | -1.7% | 0.04% | -19.6% |
Q1 2021 | $477,000 | -94.1% | 5,655 | -94.4% | 0.05% | -94.4% |
Q4 2020 | $8,048,000 | -13.5% | 100,294 | -13.3% | 0.82% | -24.3% |
Q3 2020 | $9,302,000 | -23.4% | 115,669 | -18.0% | 1.08% | -32.5% |
Q2 2020 | $12,140,000 | +3.4% | 140,994 | -2.5% | 1.60% | -14.3% |
Q1 2020 | $11,746,000 | -2.1% | 144,672 | +0.8% | 1.87% | +24.4% |
Q4 2019 | $12,001,000 | -1.1% | 143,520 | +3.5% | 1.50% | -10.4% |
Q3 2019 | $12,133,000 | +4.7% | 138,714 | -2.0% | 1.68% | +4.5% |
Q2 2019 | $11,593,000 | +6.6% | 141,546 | -1.2% | 1.60% | +1.3% |
Q1 2019 | $10,878,000 | +18.7% | 143,249 | +2.9% | 1.58% | +2.3% |
Q4 2018 | $9,165,000 | +3294.4% | 139,249 | +3876.3% | 1.55% | +3583.3% |
Q3 2018 | $270,000 | +4.7% | 3,502 | +0.1% | 0.04% | -2.3% |
Q2 2018 | $258,000 | – | 3,500 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |